Agilent Technologies and Ameritox Form Collaboration, Aim to Advance Analysis of Medication Monitoring

  Agilent Technologies and Ameritox Form Collaboration, Aim to Advance
  Analysis of Medication Monitoring

Business Wire

SANTA CLARA, Calif. & BALTIMORE -- February 11, 2013

Agilent Technologies Inc. (NYSE: A) and Ameritox^SM today announced that they
have formed a research collaboration that could accelerate analysis in the
field of medication monitoring.

“By using multiple RapidFire systems Ameritox is streamlining the analysis of
small panels of exogenous compounds compared to traditional methods of
analysis,” said Can Ozbal, director of Agilent’s RapidFire business.

While Agilent’s RapidFire system has been used extensively in pharmaceutical
and biopharmaceutical laboratories, this research collaboration with Ameritox
is one of the first for Agilent’s RapidFire team in the field of medication

“By working together and sharing moment-by-moment laboratory activity, this
research arrangement gives both Ameritox and Agilent a vantage point from
which we can continue to discover new uses for our science and technology,”
said Jay Zimmerman, chief laboratory officer of Ameritox.

“The marriage of Agilent’s technology and Ameritox’s proprietary science could
hold the key to major advancements in the field of medication monitoring,”
Zimmerman said.

About Ameritox

Ameritox is the nation’s leader in Pain Medication Monitoring Solutions^SM,
offering specialized laboratory testing and reporting services. Ameritox’s
expertise and innovative science provide physicians with insights and support
to enhance and optimize the care of chronic pain patients. Ameritox offers the
most thorough pain medication monitoring lab process – Rx Guardian^SM – with
Rx Guardian CD^SM, the only pain medication monitoring process with a
proprietary normalization algorithm and a reference database of pain patients
clinically assessed for adherence. Patient results are compared against this
database, helping physicians assess whether patients are taking their pain
medications correctly. Monitoring through prescription drug testing helps
physicians make more informed clinical decisions and manage the risks and
complexities associated with prescribing pain medications. Ameritox is
headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas
and Greensboro, N.C. Ameritox can be found online at, on
Twitter @Ameritox, on Facebook at, and on YouTube at

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company
and a technology leader in chemical analysis, life sciences, diagnostics,
electronics and communications. The company’s 20,500 employees serve customers
in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal
2012. Information about Agilent is available at

NOTE TO EDITORS: Further technology, corporate citizenship and executive news
is available at


Susan Berg, +1-408-553-7093
Lon Wagner, +1-336-387-7742
Press spacebar to pause and continue. Press esc to stop.